Skip to main content
Alexey Serov researches ways to improve hydrogen fuel cells and materials and the electrolysis process. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy

It would be a challenge for any scientist to match Alexey Serov’s rate of inventions related to green hydrogen fuel. But this researcher at ORNL has 84 patents with at least 35 more under review, so his electrifying pace is unlikely to slow down any time soon.

The AI agent, incorporating a language model-based molecular generator and a graph neural network-based molecular property predictor, processes a set of user-provided molecules (green) and produces/suggests new molecules (red) with desired chemical/physical properties (i.e. excitation energy). Image credit: Pilsun You, Jason Smith/ORNL, U.S. DOE

A team of computational scientists at ORNL has generated and released datasets of unprecedented scale that provide the ultraviolet visible spectral properties of over 10 million organic molecules. 

Naval Academy midshipmen look at tiny particle fuels while touring ORNL. Credit: Lena Shoemaker/ORNL, U.S. Dept. of Energy

Nuclear engineering students from the United States Military Academy and United States Naval Academy are working with researchers at ORNL to complete design concepts for a nuclear propulsion rocket to go to space in 2027 as part of the Defense Advanced Research Projects Agency DRACO program.

2023 Battelle Distinguished Inventors

Four scientists affiliated with ORNL were named Battelle Distinguished Inventors during the lab’s annual Innovation Awards on Dec. 1 in recognition of being granted 14 or more United States patents.

Ramesh Bhave in lab

Caldera Holding, the owner and developer of Missouri’s Pea Ridge iron mine, has entered a nonexclusive research and development licensing agreement with ORNL to apply a membrane solvent extraction technique, or MSX, developed by ORNL researchers to mined ores.

Scientists conducted microbial DNA sampling at a Yellowstone National Park hot spring for a study sponsored by DOE’s Biological and Environmental Research program, the National Science Foundation and NASA. Credit: Mircea Podar/ORNL, U.S. Dept. of Energy

Oak Ridge National Laboratory scientists studied hot springs on different continents and found similarities in how some microbes adapted despite their geographic diversity.

ORNL researchers, from left, Yang Liu, Xiaohan Yang and Torik Islam, collaborated on the development of a new capability to insert multiple genes simultaneously for fast, efficient transformation of plants into better bioenergy feedstocks. Credit: Genevieve Martin/ORNL, U.S. Dept. of Energy

In a discovery aimed at accelerating the development of process-advantaged crops for jet biofuels, scientists at ORNL developed a capability to insert multiple genes into plants in a single step.

ORNL scientists mutated amino acids in a receptor protein, shown in green, which diminished interaction with the SARS-CoV-2 virus spike protein, shown in red. Mutating the receptor protein hampered the virus’s ability to infect host cells. Credit: ORNL, U.S. Dept. of Energy

Oak Ridge National Laboratory scientists exploring bioenergy plant genetics have made a surprising discovery: a protein domain that could lead to new COVID-19 treatments.

Researchers at Oak Ridge National Laboratory discovered a tug-of-war strategy to enhance chemical separations needed to recover critical materials. Credit: Alex Ivanov/ORNL, U.S. Dept. of Energy

ORNL scientists combined two ligands, or metal-binding molecules, to target light and heavy lanthanides simultaneously for exceptionally efficient separation.

Oak Ridge National Laboratory led a team of scientists to design a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and future virus outbreaks. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy

A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.